Registration now open: Virtual ACS Forum

Registration is now open for the ACS Forum

Thursday December 3rd

10:00 – 13:00 New York (EST)

16:00 – 19:00 Amsterdam (CET)

00:00 – 03:00 (+1 day) Tokyo (JST)

Registration is now open for the ACS Forum

Thursday December 3rd

10:00 – 13:00 New York (EST)

16:00 – 19:00 Amsterdam (CET)

00:00 – 03:00 (+1 day) Tokyo (JST)

Join us for a virtual webinar event featuring presentations by ten international experts in the clinical management of patients with acute coronary syndrome. The ACS Forum is relevant for a broad healthcare professional audience, including trained cardiologists, cardiologists in training, lipidologists, other physicians, nurses, and technicians.

Discussion topics will include:

  • ACS in the Time of COVID-19
  • Drug Therapies for ACS
  • Devices in the Cath Lab
  • Unique Patient Case Studies
  • Challenging Clinical Situations in ACS, and more.

These topics reflect the educational objectives for this programme

  • Identify the latest developments related to interventions for acute coronary syndrome (ACS)
  • Review scientific and clinical insights in both the acute phase of ACS and following discharge from the hospital
  • Evaluate and discuss challenging clinical situations in ACS

On behalf of ACS Forum Chair Prof. Gilles Montalescot and the ACS Forum faculty, we invite you to register now by following the link above.

EBAC logo

The event “ACS Forum” is accredited by the European Board for Accreditation in Cardiology (EBAC) for 3 hours of External CME credits.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

The ACTION Group, based in Paris, France, is an independent non-profit academic research organisation conducting clinical trials in cardiovascular disease at a national and international level, with high impact on patient quality of life and cardiovascular outcomes.  ACTION promotes patient education based on the patient experience, creating training programs and working with patient associations.  ACTION develops educational programs for healthcare professionals to disseminate up-to-date scientific information and medical guidelines.

CORONARY CONNECT is an independent and international group of medical experts in the field of coronary heart disease. CORONARY CONNECT translates the latest scientific and clinical insights into educational programmes, supporting healthcare professionals around the world to offer the best possible care to their patients.

The ACS Forum has been developed in partnership by the ACTION Group and CORONARY CONNECT, an initiative of COR2ED.
The ACS Forum is a medical educational programme supported by an Independent Educational Grant from Amgen.